I. Katz et al., INFLUENCE OF AGE ON CYCLOSPORINE-A-INDUCED ALTERATIONS IN BONE-MINERAL METABOLISM IN THE RAT IN-VIVO, Journal of bone and mineral research, 9(1), 1994, pp. 59-67
Cyclosporin A (CsA) administered to actively growing young rats produc
es a high-turnover osteopenia. We investigated and compared the effect
of CsA on the bone mineral metabolism in young rats with that of olde
r rats, which have a lower rate of bone turnover. A group of 24 young
(9 weeks) and 24 older (9 months) male Sprague-Dawley rats were orally
administered 15 mg/kg of CsA or placebo daily for 24 days. Rats were
weighed and serum assayed serially for bone gla protein (BGP), parathy
roid hormone, ionized calcium, blood urea nitrogen, creatinine, and 1,
25-dihydroxyvitamin D [1,25-(OH)(2)D]. After sacrifice, histomorphomet
ric analysis was performed on undecalcified proximal tibial metaphysis
with double-fluorescent labeling. Serum BGP levels were significantly
elevated in both young and older rats administered CsA, and 1,25-(OH)
(2)D levels were significantly elevated in CsA-treated young rats more
than in older rats. Body weight was significantly reduced in CsA-trea
ted older rats. There were mild but significant alterations in renal f
unction in both groups receiving CsA. In the most comprehensive examin
ation to date of the effects of CsA on bone histomorphometry, both you
ng (-44%) and older rats (-20%) lost significant amounts of trabecular
bone compared to their respective controls. Bone loss in young rats w
as mainly due to a reduced number of trabeculae; older rats lost mainl
y trabecular thickness. Microanatomic nodal studies were consistent wi
th these results. These data demonstrate that although cancellous bone
loss induced by CsA is more marked in young Fats, older rats with slo
wer bone turnover are also at risk.